Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Medtronic
US Army
Cipla
Queensland Health
Chubb
Citi
Baxter
Boehringer Ingelheim

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050594

« Back to Dashboard

NDA 050594 describes ERYCETTE, which is a drug marketed by Johnson And Johnson and is included in one NDA. Additional details are available on the ERYCETTE profile page.

The generic ingredient in ERYCETTE is erythromycin. There are one hundred and two drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
Summary for 050594
Tradename:ERYCETTE
Applicant:Johnson And Johnson
Ingredient:erythromycin
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 050594

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SWAB;TOPICALStrength2% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Feb 15, 1985TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Fuji
Argus Health
Teva
UBS
Colorcon
Moodys
Healthtrust
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.